These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37407913)

  • 1. SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves.
    Bezzio C; Vernero M; Costa S; Armuzzi A; Fiorino G; Ardizzone S; Roselli J; Carparelli S; Orlando A; Caprioli FA; Castiglione F; Viganò C; Ribaldone DG; Zingone F; Monterubbianesi R; Imperatore N; Festa S; Daperno M; Scucchi L; Ferronato A; Pastorelli L; Alimenti E; Balestrieri P; Ricci C; Cappello M; Felice C; Coppini F; Alvisi P; Di Luna I; Gerardi V; Variola A; Mazzuoli S; Lenti MV; Saibeni S;
    BMC Gastroenterol; 2023 Jul; 23(1):230. PubMed ID: 37407913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.
    Macaluso FS; Giuliano A; Fries W; Viola A; Abbruzzese A; Cappello M; Giuffrida E; Carrozza L; Privitera AC; Magnano A; Ferracane C; Scalisi G; Minissale MG; Giangreco E; Garufi S; Bertolami C; Cucinotta U; Graziano F; Casà A; Renna S; Teresi G; Rizzuto G; Mannino M; Maida M; Orlando A
    Inflamm Bowel Dis; 2023 Feb; 29(2):217-221. PubMed ID: 35385102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Igg seroprevalence in IBD patients treated with biologics: first vs. second pandemic wave in a prospective study.
    Mossa M; Neri B; Montesano L; Salvatori S; Marafini I; Scucchi L; Lolli E; Massoud R; Petruzziello C; Bernardini S; Calabrese E; Monteleone G; Biancone L
    Eur Rev Med Pharmacol Sci; 2022 May; 26(10):3787-3796. PubMed ID: 35647861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible Impact of Vitamin D Status and Supplementation on SARS-CoV-2 Infection Risk and COVID-19 Symptoms in a Cohort of Patients with Inflammatory Bowel Disease.
    De Nicolò A; Cusato J; Bezzio C; Saibeni S; Vernero M; Disabato M; Caviglia GP; Ianniello A; Manca A; D'Avolio A; Ribaldone DG
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Seroprevalence Study of Anti-SARS-CoV-2 Antibodies in Patients with Inflammatory Bowel Disease during the Second Wave of the COVID-19 Pandemic in Italy.
    Di Ruscio M; Lunardi G; Buonfrate D; Gobbi F; Bertoli G; Piccoli D; Conti A; Geccherle A; Variola A
    Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684085
    [No Abstract]   [Full Text] [Related]  

  • 6. Worse impact of second wave COVID-19 pandemic in adults but not in children with inflammatory bowel disease: an Italian single tertiary center experience.
    Carparelli S; Pastore MR; Valvano MR; Marseglia A; Latiano A; Palmieri O; Guerra M; Martino G; Perri F; Bossa F
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2744-2747. PubMed ID: 33829460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic.
    Lin S; Lau LH; Chanchlani N; Kennedy NA; Ng SC
    Gut; 2022 Jul; 71(7):1426-1439. PubMed ID: 35477864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study.
    Bezzio C; Armuzzi A; Furfaro F; Ardizzone S; Milla M; Carparelli S; Orlando A; Caprioli FA; Castiglione F; Viganò C; Ribaldone DG; Zingone F; Monterubbianesi R; Imperatore N; Festa S; Daperno M; Scucchi L; Ferronato A; Pastorelli L; Balestrieri P; Ricci C; Cappello M; Felice C; Fiorino G; Saibeni S;
    Aliment Pharmacol Ther; 2021 Dec; 54(11-12):1432-1441. PubMed ID: 34694009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High seroprevalence against SARS-CoV-2 in non-vaccinated patients with inflammatory bowel disease from Northern India.
    Kante B; Vuyyuru SK; Gupta R; Dwivedi T; Kumar P; Mundhra S; Golla R; Virmani S; Verma M; Makharia G; Ahuja V; Kedia S
    Indian J Gastroenterol; 2023 Feb; 42(1):70-78. PubMed ID: 36738383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The three facets of the SARS-CoV-2 pandemic during the first two waves in the northern, central, and southern Italy.
    Buscemi S; Davoli C; Trecarichi EM; Morrone HL; Tassone B; Buscemi C; Randazzo C; Barile AM; Colombrita P; Soresi M; Giannitrapani L; Cascio A; Scichilone N; Cottone C; Sbraccia P; Guglielmi V; Leonetti F; Malavazos AE; Basilico S; Carruba M; Santini F; Antonelli A; Viola N; Romano M; Cesana BM; Torti C
    J Infect Public Health; 2023 Apr; 16(4):520-525. PubMed ID: 36801631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology, Clinical Profile, Intensive Care Needs and Outcome in Children with SARS-CoV-2 Infection Admitted to a Tertiary Hospital During the First and Second Waves of the COVID-19 Pandemic in India.
    C R V; Sharma R; Jayashree M; Nallasamy K; Bansal A; Angurana SK; L Mathew J; Sankhyan N; Dutta S; Verma S; Kumar R; Devnanai M; Vaidya PC; Samujh R; Singh MP; Goyal K; Lakshmi PVM; Saxena AK
    Indian J Pediatr; 2023 Feb; 90(2):131-138. PubMed ID: 35921029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe acute respiratory syndrome coronavirus 2 infection does not worsen the course of inflammatory bowel disease in the long term.
    Neri B; D'Agostini G; Salvatori S; Mossa M; Bettin F; Mancone R; Marafini I; Lolli E; Calabrese E; Monteleone G; Biancone L
    Eur J Gastroenterol Hepatol; 2023 Sep; 35(9):948-954. PubMed ID: 37505974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations.
    Bekic D; Belosic Halle Z
    Scand J Gastroenterol; 2021 Jun; 56(6):656-660. PubMed ID: 33765405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease.
    Scucchi L; Neri B; Sarmati L; Mossa M; Sena G; Massoud R; Petruzziello C; Musumeci M; Marafini I; Calabrese E; Lolli E; Bernardini S; Andreoni M; Monteleone G; Biancone L
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2418-2424. PubMed ID: 33755981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individuals With SARS-CoV-2 Infection During the First and Second Waves in Catalonia, Spain: Retrospective Observational Study Using Daily Updated Data.
    Alves-Cabratosa L; Comas-Cufí M; Blanch J; Martí-Lluch R; Ponjoan A; Castro-Guardiola A; Hurtado-Ganoza A; Pérez-Jaén A; Rexach-Fumaña M; Faixedas-Brunsoms D; Gispert-Ametller MA; Guell-Cargol A; Rodriguez-Batista M; Santaularia-Font F; Orriols R; Bonnin-Vilaplana M; Calderón López JC; Sabater-Talaverano G; Queralt Moles FX; Rodriguez-Requejo S; Avellana-Revuelta E; Balló E; Fages-Masmiquel E; Sirvent JM; Lorencio C; Morales-Pedrosa JM; Ortiz-Ballujera P; Ramos R
    JMIR Public Health Surveill; 2022 Jan; 8(1):e30006. PubMed ID: 34797774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical profile of hospitalized COVID-19 patients in first & second wave of the pandemic: Insights from an Indian registry based observational study.
    Kumar G; Mukherjee A; Sharma RK; Menon GR; Sahu D; Wig N; Panda S; Rao VV; Singh S; Guleria R; Bhargava B;
    Indian J Med Res; 2021 May; 153(5&6):619-628. PubMed ID: 34259194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of COVID-19 pandemic waves on changes in surgical urgency volumes and severity in the regional hospital network of Trento (Northern Italy): a descriptive epidemiological analysis.
    Carrara A; Pertile R; Amabile D; Reich F; Nava FL; Moscatelli P; Pellecchia L; Motter M; Ferro A; Valent F; Benetollo PP; Tirone G
    Epidemiol Prev; 2021; 45(6):470-476. PubMed ID: 35001595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease.
    Khan N; Mahmud N; Patel M; Sundararajan R; Reinisch W
    Aliment Pharmacol Ther; 2023 Apr; 57(7):800-807. PubMed ID: 36645110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A more frequent disease monitorering but no increased disease activity in patients with inflammatory bowel disease during the first year of the SARS-CoV-2 pandemic. A retrospective study.
    Lindhagen S; Karling P
    Scand J Gastroenterol; 2022 Feb; 57(2):169-174. PubMed ID: 34699290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of demographic, clinical and laboratory characteristics between first and second COVID-19 waves in a secondary care hospital in Qatar: a retrospective study.
    Naushad VA; Purayil NK; Chandra P; Saeed AAM; Radhakrishnan P; Varikkodan I; Mathew JV; Sirajudeen J; Hammamy RA; Badi AM; Suliman AM; Badawi MN; Arya S; AlMotawa M; Al-Baker A; Alatom R; Kartha A
    BMJ Open; 2022 Jun; 12(6):e061610. PubMed ID: 35768095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.